FEMY Femasys Inc. Net Sales Margin

Public company logo of Femasys Corp (FEMY)

The low cyclicality of demand for gynecological services ensures the resilience of Femasys Inc. (FEMY) to crises, which is confirmed by the projected sales margins, where the metric level stands at -640.90. Physician confidence is based on an innovative approach to minimally invasive diagnostics. Meanwhile, the company adheres to basic environmental standards by minimizing plastic in packaging and optimizing office energy consumption.

femasys.com (FEMY) Net Return on Sales: for the period 07/04/2022 - 11/19/2026

Summary analytical data breakdowns for Femasys Corp (FEMY)

- market value and analyst target forecast:
General company analysis:Femasys Corporation - FEMY
Manufactured product of Femasys Inc

The uniqueness of Femasys Inc. non-surgical methods allows the company to independently determine service pricing while optimizing clinic expenses. This metric measures the share of net profit in every dollar of revenue, capturing the final business efficiency after all costs. Analyzing this metric helps distinguish temporary write-offs from a systemic decline in profitability. Investors require this to assess the asset's financial stability. The trend of the company's net margin ratio clearly demonstrates the actual conversion of sales into capital.

Analysis of competing companies

Intuitive Surgical, Inc. (ISRG) - Net Margin|Net Margin Danaher Corporation (DHR)|Net Margin Becton Dickinson & Co|Net Return on Sales STE (STERIS plc)|Return on Sales by Net Profit WST (West Pharmaceutical Services Inc)|Company Net Profitability BAX|Masimo Corporation - Return on Sales by Net Profit|Company Net Profitability STVN (Stevanato Group SpA)|TFX: Return on Sales by Net Profit|Company Sales Margin Merit Medical Corp MMSI|NVST: Net Sales Margin|ICUI - Company Sales Margin|XRAY (Sirona Dental Systems) - Net Sales Margin|Net Margin LeMaitre Vascular Inc LMAT|Net Margin AtriCure Corp (ATRC)|Net Sales Margin STAAR Surgical Corp (STAA)|Net Margin niagenbioscience.com NAGE|ZimVie Inc. - Net Margin|ANGO - Net Margin|Company Sales Margin Cerus Corp CERS|TKNO (Alpha Teknova Inc) - Return on Sales by Net Profit|Monogram Technologies Inc - Net Profit Rate|Return on Sales by Net Profit STSS|InfuSystem Holdings, Inc. (INFU) - Company Sales Margin|Net Sales Margin UTMD|KORU Medical - Net Return on Sales|Nyxoah S.A - Return on Sales by Net Profit|Net Profit Rate MBOT|PDEX - Net Margin|ZTEK (Zentek) - Net Return on Sales|ELUT (Elutia Inc) - Return on Sales by Net Profit|MLSS - Company Sales Margin|Net Margin NEXGEL, Inc.|RVP (Retractable Technologies) - Company Net Profitability|Net Sales Margin HBIO|Net Sales Margin Meihua Medical Technologies (MHUA)|Net Sales Margin POAI (Predictive Oncology)|CJMB - Return on Sales by Net Profit|ATRI: Return on Sales by Net Profit|NeuroMetrix, Inc. (NURO) - Return on Sales by Net Profit